1 |
Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee [J]. Radiology, 2020, 294(1): 168-185.
|
2 |
An JY, Unsdorfer KML, Weinreb JC. BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: reporting and data systems [J]. Radio Graphics, 2019, 39(5): 1435-1436.
|
3 |
Timmerman D. Lack of standardization in gynecological ultrasonography [J]. Ultrasound Obstet Gynecol, 2000, 16(5): 395-398.
|
4 |
Levine D, Brown DL, Andreotti RF, et al. Management of Asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement [J]. Ultrasound Q, 2010, 26(3): 121-131.
|
5 |
Ueland FR, Depriest PD, Pavlik EJ, et al. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography [J]. Gynecol Oncol, 2003, 91(1): 46-50.
|
6 |
刘平, 马成斌, 陆琴, 等. RMI、MI及CA125预测卵巢肿瘤恶性危险性的价值 [J]. 同济大学学报(医学版), 2008, 29(2): 102-105.
|
7 |
Jeoung HY, Choi HS, Lim YS, et al. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors [J]. J Gynecol Oncol, 2008, 19(4): 229-235.
|
8 |
Amor F, Vaccaro H, Alcázar JL, et al. Gynecologic imaging reporting and data system [J]. J Ultrasound Med, 2009, 28(3): 285-291.
|
9 |
陈秋月, 吕国荣. GI-RADS分类在妇科附件肿块诊断中的应用 [J]. 中国超声医学杂志, 2013, 29(6): 527-530.
|
10 |
Amor F, Alcázar JL, Vaccaro H, et al. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study [J]. Ultrasound Obstet Gynecol, 2011, 38(4): 450-455.
|
11 |
Wang X, Yang S, Lv G, et al. Combination of GI-RADS and 3D-CEUS for differential diagnosis of ovarian masses [J]. Rev Assoc Med Bras, 2019, 65(7): 959-964.
|
12 |
许爱玲, 聂芳, 汪娟娟, 等. GI-RADS分级联合血清CA-125鉴别附件区肿块良恶性的临床价值 [J]. 中国临床医学影像杂志, 2018, 29(12): 881-883.
|
13 |
Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group [J]. Ultrasound Obstet Gynecol, 2000, 16(5): 500-505.
|
14 |
Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer [J]. Ultrasound Obstet Gynecol, 2008, 31(6): 681-690.
|
15 |
Timmerman D, Van Calster B, Testa AC, et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group [J]. Ultrasound Obstet Gynecol, 2010, 36(2): 226-234.
|
16 |
和平, 吴青青, 孙丽娟, 等. 对比观察ADNEX模型、简单规则风险估计模型及恶性风险指数诊断卵巢良恶性肿瘤 [J]. 中国医学影像技术, 2019, 35(1): 104-107.
|
17 |
Meys EM, Rutten IJ, Kruitwagen RF, et al. Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands [J]. BMC Cancer, 2015, 15(1): 482-488.
|
18 |
刘婧, 陈秋月, 吕国荣. 超声国际卵巢肿瘤研究组简单法则与妇科影像报告与数据系统分类诊断卵巢肿瘤的比较 [J]. 中国医学影像技术, 2017, 33(5): 739-742.
|
19 |
Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, et al. Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses [J]. JAMA Netw Open, 2020, 3(1): e1919896.
|
20 |
Andreotti RF, Timmerman D, Benacerraf BR, et al. Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR Ovarian-Adnexal Reporting and Data System Committee [J]. J Am Coll Radiol, 2018, 15(10): 1415-1429.
|
21 |
白博, 韩慧娟, 周毓青. IOTA简易原则预测卵巢肿瘤良恶性的临床价值研究 [J/CD]. 中华医学超声杂志(电子版), 2018, 15(8): 620-622.
|
22 |
Timmerman D, Van Calster B, Testa AC, et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group [J]. Ultrasound Obstet Gynecol, 2010, 36(2): 226-234.
|
23 |
Dirk Timmerman MP, Ben Van Calster MP, Antonia Testa MP, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis (IOTA) group [J]. Am J Obste Gynecol, 2016, 214(4): 424-437.
|
24 |
Sharma A, Apostolidou S, Burnell M, et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS) [J]. Ultrasound Obstet Gynecol, 2012, 40(3): 338-344.
|
25 |
Greenlee RT, Kessel B, Williams CR, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial [J]. Am J Obste Gynecol, 2010, 202(4): 371-373.
|
26 |
Vernooij F, Witteveen PO, Verweij E, et al. The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients [J]. Gynecol Oncol, 2009, 115(3): 343-348.
|
27 |
Vernooij F, Heintz P, Witteveen E, et al. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review [J]. Gynecol Oncol, 2007, 105(3): 801-812.
|
28 |
Chan JK, Kapp DS, Shin JY, et al. Influence of the gynecologic oncologist on the survival of ovarian cancer patients [J]. Obstet Gynecol, 2007, 109(6): 1342-1350.
|